Trials / Completed
CompletedNCT04458870
Acceptance and Commitment Therapy for Family Caregivers of People With Dementia
Internet-based Acceptance and Commitment Therapy for Family Caregivers of People With Dementia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The pilot project aims to investigate the feasibility and the preliminary efficacy of a guided online acceptance and commitment therapy (ACT) intervention for distressed family caregivers of people with dementia. A one-group pretest-posttest design (n=15) will be used to investigate the potential effects of the 10 weekly online ACT intervention session on caregivers' outcomes at posttest (10 weeks).
Detailed description
This project will employ one-group pretest-posttest design to investigate the potential impact of a guided online ACT intervention on improving quality of life and psychological health in distressed family caregivers of people with dementia. After the baseline evaluation, eligible caregivers will receive 10 weekly ACT sessions, individually delivered by a licensed professional counselor online. Each session lasts for one hour. Primary outcome measures will be psychological distress measured by the Depression, Anxiety and Stress Scale (DASS)- 21 and care-related quality of life measured by the Care-related Quality of Life instrument (CarerQol). A one-time interview at the completion of the 10 weekly sessions will be conducted to explore caregivers' experiences in the intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Acceptance and Commitment Therapy | Participants will receive 10 weekly individual acceptance and commitment therapy by a trained coach through zoom video-conferencing. |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2020-11-09
- Completion
- 2020-11-09
- First posted
- 2020-07-07
- Last updated
- 2020-12-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04458870. Inclusion in this directory is not an endorsement.